Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study

Open access
Bergman, Peter, Norlin, Anna-Carin, Hansen, Susanne, Rekha, Rokeya Sultana, Agerberth, Birgitta, Björkhem-Bergman, Linda, Ekström, Lena, Lindh, Jonatan D, Andersson, Jan · 2012 · BMJ Open

Abstract

Background: Low serum levels of 25-hydroxyvitamin D 3 are associated with an increased risk of respiratory tract infections (RTIs). Clinical trials with vitamin D 3 against various infections have been carried out but data are so far not conclusive. Thus, there is a need for additional randomised controlled trials of effects of vitamin D 3 on infections. Objective: To investigate if supplementation with vitamin D 3 could reduce infectious symptoms and antibiotic consumption among patients with antibody deficiency or frequent RTIs. Design: A double-blind randomised controlled trial. Setting: Karolinska University Hospital, Huddinge. Participants: 140 patients with antibody deficiency (selective IgA subclass deficiency, IgG subclass deficiency, common variable immune disorder) and patients with increased susceptibility to RTIs (>4 bacterial RTIs/year) but without immunological diagnosis. Intervention: Vitamin D 3 (4000 IU) or placebo was given daily for 1 year. Primary and secondary outcome measures: The primary endpoint was an infectious score based on five parameters: symptoms from respiratory tract, ears and sinuses, malaise and antibiotic consumption. Secondary endpoints were serum levels of 25-hydroxyvitamin D 3, microbiological findings and levels of antimicrobial peptides (LL-37, HNP1–3) in nasal fluid. Results: The overall infectious score was significantly reduced for patients allocated to the vitamin D group (202 points) compared with the placebo group (249 points; adjusted relative score 0.771, 95% CI 0.604 to 0.985, p=0.04). Limitations: A single study centre, small sample size and a selected group of patients. The sample size calculation was performed using p=0.02 as the significance level whereas the primary and secondary endpoints were analysed using the conventional p=0.05 as the significance level. Conclusions: Supplementation with vitamin D 3 may reduce disease burden in patients with frequent RTIs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2012-001663

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Bergman, P., Norlin, A.-C., Hansen, S., Rekha, R. S., Agerberth, B., Björkhem-Bergman, L., Ekström, L., Lindh, J. D., & Andersson, J.
Venue
BMJ Open
Publisher
BMJ
Published
2012
Volume
2
Issue
6
Pages
e001663
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2148450196
Cited by
189
References
3
FWCI
10.60
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.